A Paradigm Shift💡 We're thrilled to share a recent feature on our CEO/Founder Francesca Cordeiro. In her interview with The Ophthalmologist, Professor Cordeiro discusses the critical importance of early intervention in the treatment outcomes of patients with neurodegenerative conditions typified by many of those affecting the retina. She discusses the groundbreaking development of DARC (Detection of Apoptosing Retinal Cells) and the now realistic ability to detect and quantify these earliest signs of disease. Moreover, due to their shared embryological provenience, she states, "Changes in the eye almost predict changes in the brain, providing a non-invasive window to view a world that is difficult to see directly in the brain." This forward-thinking approach highlights the importance of innovative research and early treatment strategies to prevent vision loss and neurodegeneration. It's an inspiring read that underlines the significant steps being made in our field. Check out the full interview here: https://bit.ly/3PsySZY 👇 #Novai #Ophthalmology #EarlyIntervention #InnovativeMedicine #ImperialCollegeLondon #WesternEyeHospital
Sitting Down with Francesca Cordeiro, Chair and Professor of Ophthalmology at Imperial College London, and Director of the Clinical Trials Unit at Western Eye Hospital, London 💬👇🏼 https://bit.ly/3PsySZY